George J Morrow
CIK 1068754 · Exe VP, Global Commercial Ops · last filed 2026-11-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ALGN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Director | 13,186 | $169.06 | $2.23M | -$10.06M | 17 | 2026-11-03 |
| ALGN | Director | 8,309 | $175.50 | $1.46M | -$32.74M | 30 | 2026-05-22 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Director | 391 | — | — | $123 | 6 | 2018-05-24 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 3 | 2017-07-14 |
| SAFEWAY INC (SWY) Delisted | Director | — | — | — | $0 | 14 | 2015-02-02 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Director | 0 | — | — | $157.9K | 5 | 2012-08-01 |
| AMGN | Exe VP, Global Commercial Ops | 134,606 | $464.92 | $62.58M | -$4.06M | 15 | 2010-04-30 |
Recent Filings · Page 9 of 10
94 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-05-18 | ALGN | Conv (C) | +3,000 | $0 | EDGAR |
| 2009-05-08 | AMGN | Mixed | +10,419 | -$418.6K | EDGAR |
| 2009-05-01 | AMGN | Tax (F) | −1,373 | -$69.3K | EDGAR |
| 2009-04-29 | AMGN | Grant (A) | +12,000 | $0 | EDGAR |
| 2008-10-28 | AMGN | Mixed | — | -$925.0K | EDGAR |
| 2008-05-16 | ALGN | Mixed | +8,000 | $63.1K | EDGAR |
| 2008-05-14 | AMGN | Tax (F) | −26,891 | -$1.13M | EDGAR |
| 2008-05-09 | AMGN | Grant (A) | +60,658 | $0 | EDGAR |
| 2008-04-30 | AMGN | Grant (A) | +12,000 | $0 | EDGAR |
| 2007-12-11 | AMGN | Mixed | +4,634 | $241.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.